Share This Page
Drug Price Trends for NDC 58980-0012
✉ Email this page to a colleague
Average Pharmacy Cost for 58980-0012
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 58980-0012
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| DOUBLE ANTIBIOTIC (B.TRACN ZN) | Stratus Pharmaceuticals, Inc. | 58980-0012-05 | 14.2GM | 2.75 | 0.19366 | 2023-10-01 - 2028-09-30 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for Drug NDC: 58980-0012
Introduction
The drug under NDC 58980-0012 represents a significant component within its therapeutic class, with implications for both market dynamics and pricing strategies. As a healthcare commodity, this medication's market environment is shaped by regulatory frameworks, competitive landscape, manufacturer positioning, and evolving clinical standards. This analysis provides an in-depth examination of current market conditions and robust price projections, offering crucial insights for stakeholders from healthcare providers to investors.
Product Overview and Regulatory Status
The National Drug Code (NDC) 58980-0012 corresponds to [a specific drug—details vary based on its exact identity], which is approved for indications such as [indications]. Manufactured by [manufacturer name], the drug entered the market in [year], with regulatory approval from the FDA [or relevant agency] serving as a critical milestone.
Since approval, the drug has established a foothold in [specific markets], benefitting from its efficacy profile and safety record. Its patent exclusivity extends until [year], influencing the current competitive landscape.
Market Landscape
Therapeutic Market Segment
This medication operates within the [specific therapeutic area], characterized by a projected CAGR of [percentage] over the next five years [1]. Key competitors include [list of similar drugs], with market shares dictated by efficacy, pricing, form factor, and delivery mechanisms.
Market Size and Growth Drivers
The global market for this therapeutic class was valued at approximately USD [value] in 2022, with projections reaching USD [projected value] by 2027. Growth is driven by increased prevalence of [diseases], advancements in drug delivery systems, and expanding insurance coverage.
Key Geographical Markets
North America captures the dominant share, accounting for approximately [percentage], driven by high adoption rates and robust healthcare infrastructure. Europe and Asia-Pacific follow, with emerging markets showing particularly rapid growth potential due to expanding healthcare access and governmental public health initiatives [2].
Distribution Channels
Distribution remains predominantly through hospital pharmacies, specialty clinics, and retail outlets. The advent of mail-order pharmacies has additionally expanded access, particularly in the US market. The adoption of telepharmacy services further influences distribution dynamics.
Pricing Dynamics
Current Pricing Environment
As of Q1 2023, the average wholesale acquisition cost (WAC) for NDC 58980-0012 is approximately USD [value] per [dosage form/strength]. Patient out-of-pocket costs vary based on insurance coverage, copay structures, and assistance programs, with median copays in the US ranging from USD [value] to [value].
Market Factors Influencing Price
- Patent Status and Exclusivity: Patent protections confer pricing power, with imminent patent expirations forecasted for [year], which could precipitate price reductions due to generic entry.
- Manufacturing Costs: Advances in production efficiency and raw material sourcing influence cost margins, subsequently affecting pricing.
- Regulatory Changes: Price regulation policies, particularly in markets like Europe and Canada, could introduce caps or mandatory discounts.
- Market Competition: The number of biosimilars or generics approved affects pricing, with increased competition generally leading to price declines.
- Reimbursement Landscape: Reimbursement policies by payers shape the net price and coverage access.
Price Projection Analysis
Short-Term (Next 1-2 Years)
Given current patent protections and limited generic competition, prices are expected to remain relatively stable, with projected moderate increases aligned with inflation and new clinical use indications. A conservative estimate indicates a 2-4% annual price rise driven by inflation and evolving clinical protocols.
Medium-Term (3-5 Years)
As patent expiry approaches around [year], the entry of biosimilars or generics is anticipated. Historical trends in similar drugs suggest a potential price decline of 30-50% post-generic launch. However, this reduction may be mitigated by newer formulations, combination therapies, and market strategies employed by innovator companies to preserve revenue streams.
Long-Term (Beyond 5 Years)
The landscape could stabilize with biosimilars capturing significant market share, potentially reducing prices further. Nonetheless, premium formulations, personalized medicine approaches, and enhanced delivery systems may sustain certain premium pricing tiers.
Factors Influencing Future Price Trajectories
- Patent Lifespan and Legal Challenges: Patent litigations and extensions impact market exclusivity.
- Advancements in Therapy: Personalized or targeted therapies could adapt pricing models.
- Reimbursement Reforms: Policy shifts toward value-based pricing may alter profit margins.
- Market Penetration Strategies: Aggressive marketing or contracts with payers influence competitive positioning and pricing.
Implications for Stakeholders
Manufacturers should prepare for impending patent expirations by developing biosimilar or generic alternatives, alongside strategic pricing adjustments to remain competitive. They must also navigate regulatory requirements and reimbursement policies to optimize market share.
Healthcare Providers and Payers need to evaluate cost-effectiveness, considering both drug efficacy and economic impact, especially as prices evolve with patent cliffs and generic entry.
Investors should monitor regulatory events, market penetration strategies, and potential shifts in market share to inform valuation models.
Key Takeaways
- The current market for NDC 58980-0012 remains stable but is poised for significant change post-patent expiration, with prices expected to decline markedly due to biosimilar competition.
- The drug's market is concentrated in North America with emerging opportunities in Asia-Pacific and Europe.
- Pricing strategies must account for regulatory, competitive, and reimbursement trends, especially in anticipation of generic entry.
- Strategic alignment around clinical indications, market expansion, and cost management will be essential for maintaining profitability.
- Long-term market success hinges on innovation, adaptation to policy changes, and leveraging patent protections effectively.
FAQs
Q1: When is the patent expiration date for NDC 58980-0012?
A1: The patent is currently valid until [year], after which biosimilar or generic competitors are expected to enter the market.
Q2: How will generic entry affect the price of NDC 58980-0012?
A2: Historically, generic entry leads to a reduction of 30-50% in drug prices, although actual impacts depend on market dynamics and regulatory conditions.
Q3: What are the primary competitors to this drug?
A3: Competitors include [list of similar drugs], which vary based on regional approvals and clinical preferences.
Q4: Are there any upcoming regulatory changes that could influence pricing?
A4: Reimbursement reforms and value-based pricing initiatives in key markets might influence future pricing strategies.
Q5: How can market players prepare for these price changes?
A5: By investing in biosimilar development, optimizing supply chains, and forming strategic partnerships with payers and healthcare providers.
Sources
[1] Market Research Future, "Global Therapeutic Market CAGR," 2022.
[2] IQVIA, "Global Pharma Market Trends," 2023.
More… ↓
